Pre-treatment amygdala volume predicts electroconvulsive therapy response

Frontiers in Psychiatry

Volumn 5, Issue NOV, 2014, Pages

  ten Doesschate, Freek ^a   van Eijndhoven, Philip ^b,c   Tendolkar, Indira ^b,c,d   van Wingen, Guido A ^e   van Waarde, Jeroen A ^a  

^a RIJNSTATE HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY   (Netherlands)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Amygdala; Electroconvulsive therapy; Predictive value; Response; Structural MRI

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN SIZE; COHORT ANALYSIS; CONTROLLED STUDY; ELECTROCONVULSIVE THERAPY; FEMALE; HIPPOCAMPUS; HUMAN; IMAGING SOFTWARE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PROSPECTIVE STUDY;

EID: 84928333632     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2014.00169     Document Type: Article

References (37)

1. Fink M. Convulsive therapy: a review of the first 55 years. J Affect Disord (2001) 63:1-15. doi: 10.1016/S0165-0327(00)00367-0
2. Pagnin D, de Queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a meta-analytic review. J ECT (2004) 20:13-20. doi:10.1097/00124509-200403000-00004
3. Watts BV, Groft A, Bagian JP, Mills PD. An examination of mortality and other adverse events related to electroconvulsive therapy using a national adverse event report system. J ECT (2001) 27:105-8. doi:10.1097/YCT.0b013e3181f6d17f
4. Loo CK, Mahon M, Katalinic N, Lyndon B, Hadzi-Pavlovic D. Predictors of response to ultrabrief right unilateral electroconvulsive therapy. J Affect Disord (2011) 130:192-7. doi:10.1016/j.jad.2010.09.016
5. Petrides G, Fink M, Husain MM, Knapp RG, Rush AJ, Mueller M, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT (2001) 17:244-53. doi:10.1097/00124509-200112000-00003
6. Van Waarde JA, van Oudheusden LJ, Heslinga OB, Verwey B, van der Mast RC, Giltay E. Patient, treatment, and anatomical predictors of outcome in electroconvulsive therapy: a prospective study. J ECT (2013) 29(2):113-21. doi:10.1097/YCT.0b013e31827e0d02
7. Sackheim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med (1993) 328:839-46. doi:10.1056/NEJM199303253281204
8. Sackeim HA, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S, et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry (2000) 57:425-34. doi:10.1001/archpsyc.57.5.425
9. O'Connor M, Knapp R, Husain M, Rummans T, Petrides G, Smith G. The influence of age on the response of major depression to electroconvulsive therapy - a CORE report. Am J Geriatr Psychiatry (2001) 9:382-90. doi:10.1176/appi.ajgp.9.4.382
10. Lekwauwa RE, McQuoid DR, Steffens DC. Hippocampal volume as a predictor of short-term ECT outcomes in older patients with depression. Am J Geriatr Psychiatry (2005) 13:910-3. doi:10.1097/00019442-200510000-00011
11. Oudega ML, van Exel E, Wattjes MP, Comijs HC, Scheltens P, Barkhof F. White matter hyperintensities, medial temporal lobe atrophy, cortical atrophy, and response to electroconvulsive therapy in severely depressed elderly patients. J Clin Psychiatry (2009) 72:104-12. doi:10.4088/JCP.08m04989blu
12. Thoenen H. Neurotrophins and neuronal plasticity. Science (1995) 270:593-8. doi:10.1126/science.270.5236.593
13. Yu H, Chen Z. The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol Sin (2011) 32:3-11. doi:10.1038/aps.2010.184
14. Taylor SM. Electroconvulsive therapy, brain-derived neurotrophic factor, and possible neurorestorative benefit of the clinical application of electroconvulsive therapy. J ECT (2008) 24:160-5. doi:10.1097/YCT.0b013e3181571ad0
15. Bellani M, Baiano M, Brambilla P. Brain anatomy of major depression II. Focus on amygdala. Epidemiol Psychiatr Sci (2011) 20:33-6. doi:10.1017/S2045796011000096
16. Cotter D, Pariante C, Everall I. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull (2001) 55:585-95. doi:10.1016/S0361-9230(01)00527-5
17. Taliaz D, Stall N, Dar DE, Zangen A. Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. Mol Psychiatry (2010) 15:80-92. doi:10.1038/mp.2009.67
18. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature (2008) 455:894-902. doi:10.1038/nature07455
19. Altar CA, Whitehead RE, Chen R, Wörtwein G, Madsen TM. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol Psychiatry (2003) 54:703-9. doi:10.1016/S0006-3223(03)00073-8
20. Jacobsen JPR, Mørk A. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res (2004) 1024:183-92. doi:10.1016/j.brainres.2004.07.065
21. Conti B, Maier R, Barr AM, Morale MC, Lu X, Sanna PP, et al. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Mol Psychiatry (2007) 12(2):167-89. doi:10.1038/sj.mp.4001897
22. Gersner R, Toth E, Isserles M, Zangen A. Site-specific antidepressant effects of repeated subconvulsive electrical stimulation: potential role of brain-derived neurotrophic factor. Biol Psychiatry (2010) 67:125-32. doi:10.1016/j.biopsych.2009.09.015
23. Maigaard K, Hageman I, Jørgensen A, Jørgensen MB, Wörtwein G. Electroconvulsive stimulations prevent chronic stress-induced increases in L-type calcium channel mRNAs in the hippocampus and basolateral amygdala. Neurosci Lett (2012) 516(1):24-8. doi:10.1016/j.neulet.2012.03.043
24. Nibuya M, Morinobu S, Duman R. Regulation of BDNF and TRKB messenger-RNA in rat-brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci (1995) 15:7539-47.
25. Tendolkar I, van Beek M, van Oostrom I, Mulder M, Janzig J, Oude Voshaar R, et al. Electroconvulsive therapy increases hippocampal and amygdala volume in therapy refractory depression: a longitudinal pilot study. Psychiatry Res (2013) 214:197-203. doi:10.1016/j.pscychresns.2013.09.004
26. Van Waarde JA, van Oudheusden LJB, Verwey B, Giltay EJ, van der Mast RC. Clinical predictors of seizure threshold in electroconvulsive therapy: a prospective study. Eur Arch Psychiatry Clin Neurosci (2012) 263(2):167-75. doi:10.1007/s00406-012-0342-7
27. Montgomery S, Asberg M. New depression scale designed to be sensitive to change. Br J Psychiatry (1979) 134:382-9. doi:10.1192/bjp.134.4.382
28. Zimmerman M, Posternak MA, Chelminski I. Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression. J Psychiatr Res (2004) 38:577-82. doi:10.1016/j.jpsychires.2004.03.007
29. Van Waarde JA, Scholte HS, van Oudheusden LJB, Verwey B, Denys D, van Wingen GA. A functional MRI marker may predict the outcome of electronconvulsive therapy in treatment-resistant depression. Mol Psychiatry (2014). doi:10.1038/mp.2014.78
30. Van Eijndhoven P, van Wingen G, van Oijen K, Rijpkema M, Goraj B, Verkes RJ. Amygdala volume marks the acute state in the early course of depression. Biol Psychiatry (2009) 65:812-8. doi:10.1016/j.biopsych.2008.10.027
31. Elizagarate E, Cortes J, Pinto A, Gutierrez M, Alonso I, Alcorta P, et al. Study of the influence of electroconvulsive therapy or cerebral blood flow by HMPAO-SPECT. J Affect Disord (2001) 65:55-9. doi:10.1016/S0165-0327(00)00200-7
32. Mervaala E, Könönen M, Föhr J, Husso-Saastamoinen M, Valkonen-Korhonen M, Kuikka JT, et al. SPECT and neuropsychological performance in severe depression treated with ECT. J Affect Disord (2001) 66:47-58. doi:10.1016/S0165-0327(00)00288-3
33. Vangu M, Esser J, Boyd I, Berk M. Effects of electroconvulsive therapy on regional cerebral blood flow measured by (99m) technetium HMPAO SPECT. Prog Neuropsychopharmacol Biol Psychiatry (2003) 27:15-9. doi:10.1016/S0278-5846(02)00309-3
34. Suwa T, Namiki C, Takaya S, Oshita A, Ishizu K, Fukuyama H, et al. Corticolimbic balance shift of regional glucose metabolism in depressed patients treated with ECT. J Affect Disord (2012) 136:1039-46. doi:10.1016/j.jad.2011.11.040
35. Dukart J, Regen F, Kherif F, Colla M, Bajbouj M, Heuser I, et al. Electroconvulsive therapy-induced brain plasticity determines therapeutic outcome in mood disorders. Proc Natl Acad Sci U S A (2013) 111(3):1156-61. doi:10.1073/pnas.1321399111
36. Michael N, Erfurth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B. Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression. Neuropsychopharmacology (2003) 28:720-5. doi:10.1038/sj.npp.1300085
37. Bennett DM, Perrin JS, Currie J, Blacklaw L, Kuriakose J, Rao A, et al. A comparison of ECT dosing methods using a clinical sample. J Affect Disord (2012) 141:222-6. doi:10.1016/j.jad.2012.02.033